Sector ratings Natera, Inc.

Equities

Market Closed - Nasdaq Other stock markets 06:00:00 14/04/26 am AEST			5-day change	1st Jan Change
201.90 ^USD	+4.60%		-1.45%	-11.87%

09:20pm	William Blair Initiates Natera at Outperform	MT
14/04	Natera, Inc. Highlights Allogene Therapeutic's Positive Interim Futility Analysis From Allogene Therapeutics MRD-Guided Alpha3 Trial In Large B-Cell Lymphoma	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NATERA, INC.	28.62B	-	BB	-		-
SONIC HEALTHCARE LIMITED	6.88B		AA
RADNET, INC.	4.36B	-	A	-		-
DR. LAL PATHLABS LIMITED	2.46B		A
FLEURY S.A.	1.87B		AA
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	1.79B		AA			-
GENEDX HOLDINGS CORP.	1.79B	-	BBB	-		-
DIAN DIAGNOSTICS GROUP CO.,LTD.	1.65B		-
VIJAYA DIAGNOSTIC CENTRE LIMITED	1.09B		-
H.U. GROUP HOLDINGS, INC.	1.09B		AAA
NEOGENOMICS, INC.	1.04B	-	AA	-		-
METROPOLIS HEALTHCARE LIMITED	1.02B		BB
BML, INC.	928M	-	AA	-		-	-
OPKO HEALTH, INC.	888M	-	BBB	-		-
NOVOGENE CO., LTD.	851M		-			-
THYROCARE TECHNOLOGIES LIMITED	674M	-	-	-		-
SMO CLINPLUS CO.,LTD.	667M	-	-	-		-	-
INTEGRAL DIAGNOSTICS LIMITED	592M		AA
LANDFAR BIO-MEDICINE CO., LTD	488M	-	-	-	-	-	-	-
SHANGHAI MODEL ORGANISMS CENTER, INC.	485M	-	-	-	-	-	-	-
Average	2.96B		AA
Weighted average by Cap.			AA